
The latest in contrast delivery technology enhances image quality while keeping the safety of the patient a top priority. P3T Cardiac computes custom injection protocols as well as scan timing for each patient, enabling personalized care while maintaining efficient workflow.
Intended for use when imaging the coronary arteries and chambers of the heart during either prospectively gated or retrospectively tagged acquisitions.

*P3T Cardiac is powered by MEDRAD’s Personalized Patient Protocol Technology. P3T is the technology that will support a suite of products intended to provide personalized medicine in the CT imaging environment. P3T Cardiac is the first P3T product release and was developed in conjunction with clinical experts with significant expertise and knowledge in individualized contrast protocols.
P3T Cardiac utilizes three components to compute personalized contrast injection protocols:

Blind study shows that 100% of the P3T Cardiac images were diagnostic quality, while only 93% of the control group images were diagnostic quality.
Data submitted with the 510(k): Computerized patient-based dosing of contrast media delivery at dual-source CT coronary angiography, H. Lee1, P. Suranyi1, J.F. Kalafut2, C.A. Kemper2, J.A. Abro1, P.G. Kogos1, P. Costello1, U.J. Schoepf1; 1Charleston, SC/US, 2Pittsburgh, PA/US
P3T Cardiac is easy to operate and employs the same user interface that is currently found on Stellant D. For example, patient weight is entered by selecting from a list of weight ranges, as shown.
“Using (P3T Cardiac) significantly enhances vascular attenuation especially in the distal segments of the coronary tree facilitating the evaluation of these segments.”
“With (P3T Cardiac) attenuation values throughout the scan are more homogeneous than with fixed injection protocols.”
“In patients with a low cardiac output it is important to individually adapt the scan delay and the flow rate. Injection protocols using a fixed amount of contrast medium and bolus triggering techniques will often result in insufficient opacification of the left ventricle and the coronary arteries.”
Harald Seifarth MD
Department of Clinical Radiology
University of Muenster
Adjusting Contrast by Beth W. Orenstein, Radiology Today 25 Feb. 2008.